CME REVIEW ARTICLEStevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature
REFERENCES (180)
Acute disseminated epidermal necrosis types 1, 2, and 3: study of sixty cases
J Am Acad Dermatol
(1985)- et al.
Epidemiology of erythema exudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990–1992): structure and results of a population-based registry
J Clin Epidemiol
(1996) - et al.
Analysis of the acute ophthalmic manifestations of the erythema multiforme/ Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum
Ophthalmology
(1995) - et al.
HLA typing in patients with ocular manifestation of Stevens-Johnson syndrome
Ophthalmology
(1996) - et al.
Episodic conjunctival inflammation after Stevens-Johnson syndrome
Ophthalmology
(1988) - et al.
Immune complexes in erythema multiforme and the Stevens-Johnson syndrome
J Invest Dermatol
(1980) - et al.
Erythema multiforme and Stevens-Johnson syndrome: descriptive and therapeutic controversy
Chest
(1990) - et al.
Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis
J Am Acad Dermatol
(1999) - et al.
Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis
J Am Acad Dermatol
(1989) - et al.
Drug-induced toxic epidermal necrolysis in children
J Pediatr Surg
(1989)
Efficacy of cyclophosphamide in toxic epidermal necrolysis
J Am Acad Dermatol
(1991)
Toxic epidermal necrolysis: an approach to management using cryopreserved allograft skin
J Am Acad Dermatol
(1987)
Erythema multiforme: clinical, histopathologic, and immunologic study
J Am Acad Dermatol
(1984)
Epithelial hyperproliferation and transglutaminase 1 gene expression in Stevens-Johnson syndrome conjunctiva
Am J Pathol
(1999)
Randomized comparison of thalidomide versus placebo in toxic epidermal necrolysis
Lancet
(1998)
Renal disease associated with toxic epidermal necrolysis (Lyell's disease) (Lyell's disease)
Am J Med
(1974)
Toxic epidermal necrolysis (Lyell syndrome)
Am J Acad Dermatol
(1990)
Toxic epidermal necrolysis
Med Clin North Am
(1980)
A case of contact dermatitis, erythema multiforme, and toxic epidermal necrolysis
J Am Acad Dermatol
(1981)
A new eruptive fever associated with stomatitis and ophthalmia: report of two cases in children
Am J Dis Child
(1922)
The so-called Stevens-Johnson syndrome
BMJ
(1950)
Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme
Arch Dermatol
(1993)
The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification
J Invest Dermatol
(1994)
Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes
Arch Dermatol
(1995)
Requiem for toxic epidermal necrolysis
Br J Dermatol
(1990)
Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme
J Dermatol
(1997)
Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes
J Am Acad Dermatol
(1983)
Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson syndrome: contribution of perforin-positive cell infiltration
Arch Dermatol
(1997)
Erythema multiforme: response to corticosteroid
Dermatologica
(1984)
Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis
Br J Dermatol
(1996)
Severe cutaneous reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection
Arch Dermatol
(1991)
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: a population-based study with particular reference to reactions caused by drugs among outpatients
Arch Dermatol
(1990)
Toxic epidermal necrolysis and Stevens-Johnson syndrome: an epidemiologic study from West Germany
Arch Dermatol
(1991)
A population-based study of Stevens-Johnson syndrome: incidence and antecedent drug exposure
Arch Dermatol
(1991)
European network for the case-population surveillance of rare diseases (Euronet): a prospective feasibility study
Eur J Clin Pharmacol
(1998)
Epidemiologic approaches to the study of toxic epidermal necrolysis
J Invest Dermatol
(1994)
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
N Engl J Med
(1995)
Metabolic predisposition to cutaneous adverse drug reactions: role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants
Arch Dermatol
(1995)
Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding patho-genesis
Ann Allergy
(1994)
StevensJohnson syndrome (SJS): effectiveness of corticosteroids in management and recurrent SJS
Allergy Proc
(1992)
HLA antigens in Stevens-Johnson syndrome with ocular involvement
Arch Ophthalmol
(1982)
Rapidly progressive bronchiolitis obliterans associated with Stevens-Johnson syndrome
Chest
(1990)
Incidence of toxic epidermal necrolysis in Italy
Arch Dermatol
(1990)
Drug induced febrile mucocutaneous syndrome
Acta Med Scand
(1975)
Improved treatment of the Stevens-Johnson syndrome
Arch Surg
(1984)
Toxic epidermal necrolysis syndrome: mortality reduced with early referral to regional burn center
Plast Reconstr Surg
(1998)
Vitamin A in Stevens-Johnson syndrome
Ann Ophthalmol
(1989)
Hyperamylasemia in toxic epidermal necrolysis
Arch Dermatol
(1993)
Burn treatment for the unburned
JAMA
(1987)
Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients
Arch Dermatol
(1987)
Cited by (0)
Dr Foster is currently with The Ocular Immunology and Uveitis Foundation, Massachusetts Eye Research and Surgery Institute, Boston, MA. None of the authors have financial interests in any of the medications or products mentioned in this article.
Yassine J. Daoud is the recipient of the Doris Duke Charitable Foundation and Harvard Medical School PASTEUR Clinical Research Fellowship.
This feature is supported by an unrestricted educational grant from AstraZeneca LP
Copyright © 2005 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.